Treatment of persistent or relapsing advanced germ cell neoplasms with cisplatin, etoposide and bleomycin
- 1 May 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (5) , 595-599
- https://doi.org/10.1016/0277-5379(86)90049-0
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Acute nonlymphocytic leukemia following treatment of testicular cancer and gastric cancer with combination chemotherapy not including alkylating agents: Report of two casesAmerican Journal of Hematology, 1985
- VP-16–213 and cisplatin in the treatment of patients with refractory germ cell tumorsAmerican Journal of Clinical Oncology, 1984
- VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasmsCancer Chemotherapy and Pharmacology, 1982
- VAB-3 combination chemotherapy of metastatic testicular cancerCancer, 1981
- A phase II study of oral VP-16-213 in non-seminomatous testicular cancerPublished by Elsevier ,1981
- VP16-213 as a single agent in advanced testicular tumorsPublished by Elsevier ,1980
- COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMAThe Lancet, 1979
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- EPIPODOPHYLLIN DERIVATIVE (VP 16-213) IN TREATMENT OF SOLID TUMOURSThe Lancet, 1977
- EPIPODOPHYLLIN DERIVATIVE (VP 16-213) IN MALIGNANT TERATOMAS AND CHORIOCARCINOMASThe Lancet, 1977